What is the share price of Asston Pharmaceuticals Ltd (APL) today?
The share price of APL as on 12th December 2025 is ₹87.80. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Asston Pharmaceuticals Ltd (APL) share?
The past returns of Asston Pharmaceuticals Ltd (APL) share are- Past 1 week: -6.18%
- Past 1 month: 15.57%
- Past 3 months: -15.70%
- Past 6 months: -29.73%
- Past 1 year: -29.73%
- Past 3 years: N/A%
- Past 5 years: -29.73%
What are the peers or stocks similar to Asston Pharmaceuticals Ltd (APL)?
The peers or stocks similar to Asston Pharmaceuticals Ltd (APL) include:What is the market cap of Asston Pharmaceuticals Ltd (APL) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Asston Pharmaceuticals Ltd (APL) is ₹74.74 Cr as of 12th December 2025.What is the 52 week high and low of Asston Pharmaceuticals Ltd (APL) share?
The 52-week high of Asston Pharmaceuticals Ltd (APL) is ₹126 and the 52-week low is ₹75.21.What is the PE and PB ratio of Asston Pharmaceuticals Ltd (APL) stock?
The P/E (price-to-earnings) ratio of Asston Pharmaceuticals Ltd (APL) is 19.36. The P/B (price-to-book) ratio is 6.78.Which sector does Asston Pharmaceuticals Ltd (APL) belong to?
Asston Pharmaceuticals Ltd (APL) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Asston Pharmaceuticals Ltd (APL) shares?
You can directly buy Asston Pharmaceuticals Ltd (APL) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Asston Pharmaceuticals Ltd
APL Share Price
87.801.34% (-1.19)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
APL Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
HighStrong financials and growth story over the years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
APL Performance & Key Metrics
APL Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | 6.78 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.65 | 5.78 | 0.59% |
APL Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
APL Company Profile
Asston Pharmaceuticals Limited manufactures and exports pharmaceutical formulations and nutraceutical products including tablets, capsules, oral liquids, external preparations, and oral powders primarily serving domestic and African markets.
SUNPHARMA
PE Ratio
39.37
39.37
1Y Return
0.66%
0.66%
Buy Reco %
91.67
91.67
TORNTPHARM
PE Ratio
67.14
67.14
1Y Return
13.93%
13.93%
Buy Reco %
76.92
76.92
CIPLA
PE Ratio
23.25
23.25
1Y Return
4.98%
4.98%
Buy Reco %
70.00
70.00
DRREDDY
PE Ratio
18.83
18.83
1Y Return
2.72%
2.72%
Buy Reco %
41.94
41.94
LUPIN
PE Ratio
29.43
29.43
1Y Return
0.28%
0.28%
Buy Reco %
72.22
72.22
APL Forecast
APL Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
APL
APL
Income
Balance Sheet
Cash Flow
Annual Normal View
APL Income Statement
APL Income Statement
Annual Normal View
| Financial Year | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 10.56 | 7.19 | 16.28 | 25.61 | — | |||||
Raw Materials | 6.70 | 2.68 | 9.75 | 14.14 | — | |||||
| Power & Fuel Cost | 0.00 | 0.00 | 0.01 | 0.14 | ||||||
| Employee Cost | 0.26 | 0.23 | 0.19 | 1.06 | ||||||
| Selling & Administrative Expenses | 2.00 | 1.42 | 2.13 | 3.17 | ||||||
| Operating & Other expenses | 0.99 | 0.69 | 0.12 | 1.09 | ||||||
EBITDA | 0.61 | 2.17 | 4.08 | 6.01 | — | |||||
| Depreciation/Amortization | 0.01 | 0.04 | 0.06 | 0.04 | — | |||||
| PBIT | 0.60 | 2.13 | 4.02 | 5.97 | — | |||||
| Interest & Other Items | 0.43 | 0.72 | 0.76 | 0.95 | — | |||||
| PBT | 0.17 | 1.41 | 3.26 | 5.02 | — | |||||
| Taxes & Other Items | 0.05 | 0.36 | 0.82 | 1.16 | — | |||||
| Net Income | 0.12 | 1.05 | 2.44 | 3.86 | — | |||||
| EPS | 0.21 | 1.87 | 4.11 | 6.15 | — | |||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | — | |||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | — |
APL Company Updates
APL Stock Peers
APL Past Performance & Peer Comparison
APL Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Asston Pharmaceuticals Ltd | 19.36 | 6.78 | — |
| Sun Pharmaceutical Industries Ltd | 39.37 | 5.94 | 0.89% |
| Torrent Pharmaceuticals Ltd | 67.14 | 16.91 | 0.84% |
| Cipla Ltd | 23.25 | 3.92 | 1.05% |
APL Stock Price Comparison
Compare APL with any stock or ETFCompare APL with any stock or ETF
APL
APL Holdings
APL Shareholdings
APL Promoter Holdings Trend
APL Promoter Holdings Trend
APL Institutional Holdings Trend
APL Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Decreased Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has decreased by 3.67%
APL Shareholding Pattern
APL Shareholding Pattern
APL Shareholding History
APL Shareholding History
Foreign Institutions
smallcases containing APL stock
smallcases containing APL stock
Looks like this stock is not in any smallcase yet.
APL Events
APL Events
APL Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
APL has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
APL Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
APL has not given any dividends in last 5 years
APL Dividends
APL Dividends
Hmm, looks like data is unavailable here. Please come back after some timeAPL Stock News & Opinions
APL Stock News & Opinions
Articles & Videos
Corporate
Asston Pharmaceuticals to table results
Asston Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live
4 weeks agoCapital Market - Live
Corporate
Asston Pharmaceuticals to conduct board meeting
Asston Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 16 October 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Asston Pharmaceuticals to convene AGM
Asston Pharmaceuticals announced that the 6th Annual General Meeting(AGM) of the company will be held on 29 September 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Asston Pharmaceuticals to convene board meeting
Asston Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 25 August 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Spotlight
BSE SME Asston Pharma's market entry misses the prescription for gains
The scrip was listed at Rs 119, a discount of 3.25% compared with the initial public offer (IPO) price. The stock is currently down 0.88% over its listing price. The counter hit a high of Rs 120 and a low of Rs 113.05. About 6.18 lakh shares of the company changed hands at the counter. Asston Pharmaceuticals' IPO was subscribed 173.53 times. The issue opened for bidding on 9 July 2025 and it closed on 11 July 2025. The price band of the IPO was set at Rs 115 to Rs 123 per share. The IPO comprised fresh issue of 22,41,000 equity shares. The promoter and promoter group shareholding diluted to 50.66% from 68.76% pre-issue. The company intends to utilize the net proceeds to fund capital expenditure requirements for acquiring machinery for the manufacturing unit, to finance the incremental working capital needs of the company, to repay and/or prepay, in part or in full, certain outstanding borrowings and for general corporate purposes. Ahead of the Asston Pharmaceuticals on 8 July 2025, raised Rs 7.81 crore from anchor investors. The board has allotted 6.35 lakh shares at Rs 123 per share to 4 anchor investors. Asston Pharmaceuticals manufactures and exports pharmaceutical formulations and nutraceutical products across India, as well as to several African and Asian markets. Its product range includes tablets, capsules, oral liquids, external preparations like ointments, creams, gels, and lotions, as well as oral powders such as sachets and dry syrups. Alongside its own branded products, the company also operates on a loan license and contract manufacturing basis for other marketers. As of now, Asston employs 46 permanent and 6 contractual staff across departments. The company recorded revenue from operations of Rs 6.19 crore and net profit of Rs 1.32 crore for the period ended 31 May 2025. Powered by Capital Market - Live
4 months agoCapital Market - Live
Pledged promoter holdings is insignificant